PPQ-102 is primarily used in research settings as a selective inhibitor of specific protein kinases involved in inflammatory pathways. It shows promise in modulating cellular responses associated with chronic inflammation and autoimmune conditions. Due to its ability to cross cell membranes efficiently, it is often utilized in in vitro studies to investigate signal transduction mechanisms. Its stability under physiological conditions makes it suitable for long-duration cell culture experiments. Additionally, PPQ-102 has been explored for its potential in oncology research, where it helps elucidate the role of kinase activity in tumor cell proliferation and survival. It is not intended for therapeutic use in humans at this stage.